Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
CONCLUSIONS: High-dose tacrolimus might play a role in improving allograft survival in HLA or MICA Ab+ post-transplant patients. Increasing tacrolimus concentration might be a plausible treatment for Ab+ post-transplant patients.
PMID: 26281147 [PubMed - indexed for MEDLINE]
Source: Clinical Transplants - Category: Transplant Surgery Tags: Clin Transpl Source Type: research
More News: Bone Graft | Genetics | Prograf | Proteinuria | Tacrolimus | Transplant Surgery | Transplants